This Year in Medicine 2022: The Top HCPLive Stories of the Year


As we begin our annual health care recap series this month, let's take a look back at the stories our readers liked most.

This Year in Medicine 2022: The Top HCPLive Stories of the Year

The most-read article on HCPLive this year was a summary of research into the benefit of real-time continuous glucose monitoring (CGM) on HbA1c reduction.

Is that surprising? Maybe a little disappointing? What about an article on omega-3 fatty acids for atrial fibrillation (AFib) risk reduction? A video interview on heart failure guidelines? These are hardly the outstanding headlines of 2022, yet they are among our most popular posts in these last 12 months.

We tend to believe the exceptional, the odd, or the exceptionally odd are what get the most attention in the news. In reality, the most popular stories have a streak of commonality: what affects the most will be read about the most. Think about those above stories; few chronic diseases are as prevalent and burdensome in the US than diabetes and cardiovascular disease.

Now think about the intent of those articles: updates on disease monitoring, risk reduction, guidelines and strategies. Few things better encapsulate the interests of our modern health care work force than desires to better manage, mitigate and prepare for preventable disease. This all tracks with what our audience most enjoyed from us this year.

This month, we want to share the ways how these commonly desired developments led to exceptional results in medicine through 2022.

Welcome back to This Year In Medicine, HCPLive’s annual recap series that reflects on the greatest stories, trends, issues and solutions in each specialty of our coverage. Every Monday, Wednesday and Friday of December, our team will be sharing stories and expert-driven content that speaks to the major development of health care; from RSV to colon cancer screening, from patient-reported outcomes to blindness-fighting drugs.

We’ll additionally be sharing materials from our sister publications in the greater HCPLive Network, highlighting the diversity of our coverage and the growing interplay of specialty care teams:

  • NeurologyLive
  • Contagion
  • CGTLive
  • Contemporary Pediatrics
  • Contemporary OB/GYN

You can follow along the recap on Facebook, Twitter and LinkedIn, using the hashtag #ThisYearInMedicine, and each new entry will be shared on the HCPLive homepage as well as through our daily newsletter.

We hope you enjoy reflecting on the common stories that came to mean much more for medicine in 2022. For now, check out our 10 most read stories of the year:

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Fezolinetant Changes Menopause Management, with JoAnn Vensko Pinkerton, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.